|
2VPJ
Crystal structure of the Kelch domain of human KLHL12
Deposited 2008-02-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
268–567(300 aa)
Fragment:KELCH DOMAIN, RESIDUES 268-567
|
Not recorded
|
ACT ACETATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.6;0.2M AMMONIUM ACETATE, 0.1M SODIUM ACETATE PH4.6, 30% PEG4K
|
Resolution 1.85 Å
R-free 0.222
|
|
6TTK
Crystal structure of the kelch domain of human KLHL12 in complex with DVL1 peptide
Deposited 2019-12-27
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
268–567(300 aa)
|
Not recorded
|
NA SODIUM ION × 1
EDO 1,2-ETHANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277.15 K;30% PEG4000, 0.2 M ammonium acetate, 0.1 M acetate pH 4.6
|
Resolution 2.38 Å
R-free 0.251
|
|
6TTK
Crystal structure of the kelch domain of human KLHL12 in complex with DVL1 peptide
Deposited 2019-12-27
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
268–567(300 aa)
|
Not recorded
|
NA SODIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277.15 K;30% PEG4000, 0.2 M ammonium acetate, 0.1 M acetate pH 4.6
|
Resolution 2.38 Å
R-free 0.251
|
|
6TTK
Crystal structure of the kelch domain of human KLHL12 in complex with DVL1 peptide
Deposited 2019-12-27
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
268–567(300 aa)
|
Not recorded
|
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277.15 K;30% PEG4000, 0.2 M ammonium acetate, 0.1 M acetate pH 4.6
|
Resolution 2.38 Å
R-free 0.251
|
|
6TTK
Crystal structure of the kelch domain of human KLHL12 in complex with DVL1 peptide
Deposited 2019-12-27
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
268–567(300 aa)
|
Not recorded
|
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277.15 K;30% PEG4000, 0.2 M ammonium acetate, 0.1 M acetate pH 4.6
|
Resolution 2.38 Å
R-free 0.251
|
|
6V7O
Structural Elucidation of Peptide Binding to KLHL-12, a Substrate Specific Adapter Protein in a Cul3-Ring E3 Ligase Complex
Deposited 2019-12-09
|
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
268–567(300 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;292 K;Sodium cacodylate, Sodium citrate
|
Resolution 2.90 Å
R-free 0.254
|
|
6V7O
Structural Elucidation of Peptide Binding to KLHL-12, a Substrate Specific Adapter Protein in a Cul3-Ring E3 Ligase Complex
Deposited 2019-12-09
|
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
268–567(300 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;292 K;Sodium cacodylate, Sodium citrate
|
Resolution 2.90 Å
R-free 0.254
|
|
8RBH
Crystal structure of the kelch domain of human KLHL12 in complex with PEF1 peptide
Deposited 2023-12-04
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
268–567(300 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 1
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293.15 K;0.1 M BIS-TRIS pH 5.5, 200 mM NaCl, and 30% PEG4K. (1:1)
|
Resolution 1.88 Å
R-free 0.258
|
|
8RBH
Crystal structure of the kelch domain of human KLHL12 in complex with PEF1 peptide
Deposited 2023-12-04
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
268–567(300 aa)
|
Not recorded
|
NA SODIUM ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293.15 K;0.1 M BIS-TRIS pH 5.5, 200 mM NaCl, and 30% PEG4K. (1:1)
|
Resolution 1.88 Å
R-free 0.258
|
|
9Y8J
Crystal structure of the Kelch domain of human KLHL12 with compound 1
Deposited 2025-09-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
279–567(289 aa)
|
Not recorded
|
A1CTS 2-(1H-1,3-benzimidazol-1-yl)-N-(2-fluorophenyl)acetamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;0.1M Bis-Tris pH 5.5, 0.2M MgCl2 and 25% PEG3350
|
Resolution 2.70 Å
R-free 0.329
|
|
9Y8K
Crystal structure of the Kelch domain of human KLHL12 with compound 7k
Deposited 2025-09-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
279–567(289 aa)
|
Not recorded
|
A1CTR 2-(2-amino-4-methyl-1H-1,3-benzimidazol-1-yl)-N-(2,4,6-trichlorophenyl)acetamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;0.1M Bis-Tris pH 5.5, 0.2M MgCl2 and 25% PEG3350
|
Resolution 1.27 Å
R-free 0.191
|
|
9Y8L
Crystal structure of the Kelch domain of human KLHL12 with compound 8e
Deposited 2025-09-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
279–567(289 aa)
|
Not recorded
|
A1CTQ 2-(2-amino-5,6-dimethyl-1H-1,3-benzimidazol-1-yl)-N-(2,4,6-trichlorophenyl)acetamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;0.1M Bis-Tris pH 5.5, 0.2M MgCl2 and 25% PEG3350
|
Resolution 1.27 Å
R-free 0.193
|
|
9Y8M
Crystal structure of the Kelch domain of human KLHL12 with compound 8i
Deposited 2025-09-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
279–567(289 aa)
|
Not recorded
|
A1CTE 2-(2-amino-5-fluoro-4-methyl-1H-1,3-benzimidazol-1-yl)-N-(2,4,6-trichlorophenyl)acetamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;0.1M Bis-Tris pH 5.5, 0.2M MgCl2 and 25% PEG3350
|
Resolution 1.33 Å
R-free 0.178
|
|
9Y8N
Crystal structure of the Kelch domain of human KLHL12 with compound 8m
Deposited 2025-09-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
279–567(289 aa)
|
Not recorded
|
A1CTL 2-(4-methyl-1H-imidazo[4,5-c]pyridin-1-yl)-N-(2,4,6-trichlorophenyl)acetamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;0.1M Bis-Tris pH 5.5, 0.2M MgCl2 and 25% PEG3350
|
Resolution 1.31 Å
R-free 0.204
|
|
9Y8O
Crystal structure of the Kelch domain of human KLHL12 with compound 9c
Deposited 2025-09-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
279–567(289 aa)
|
Not recorded
|
A1CTM 2-(2-amino-4-methyl-1H-1,3-benzimidazol-1-yl)-N-[2,6-dichloro-4-(phenoxyacetyl)phenyl]acetamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;0.1M Bis-Tris pH 5.5, 0.2M MgCl2 and 25% PEG3350
|
Resolution 1.29 Å
R-free 0.177
|
|
9Y8Q
Crystal structure of the Kelch domain of human KLHL12 with compound 9e
Deposited 2025-09-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
279–567(289 aa)
|
Not recorded
|
A1CTO 2-(2-amino-4-methyl-1H-1,3-benzimidazol-1-yl)-N-(2,6-dichloro-4-{[(propan-2-yl)oxy]methyl}phenyl)acetamide × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;0.1M Bis-Tris pH 5.5, 0.2M MgCl2 and 25% PEG3350
|
Resolution 1.20 Å
R-free 0.152
|
|
9Y8R
Crystal structure of the Kelch domain of human KLHL12 with compound 9h
Deposited 2025-09-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
279–567(289 aa)
|
Not recorded
|
A1CTP 2-(2-amino-4-methyl-1H-1,3-benzimidazol-1-yl)-N-[2-chloro-4-(hydroxymethyl)-3-methylphenyl]acetamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;0.1M Bis-Tris pH 5.5, 0.2M MgCl2 and 25% PEG3350
|
Resolution 1.33 Å
R-free 0.173
|
|
9Y8S
Crystal structure of the Kelch domain of human KLHL12 with compound 9k
Deposited 2025-09-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
279–567(289 aa)
|
Not recorded
|
A1CTN 4-[2-(2-amino-4-methyl-1H-1,3-benzimidazol-1-yl)acetamido]-N-benzyl-3-chloro-2-methylbenzamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;0.1M Bis-Tris pH 5.5, 0.2M MgCl2 and 25% PEG3350
|
Resolution 1.29 Å
R-free 0.170
|
|
9Y8T
Crystal structure of the Kelch domain of human KLHL12 with compound 10b
Deposited 2025-09-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
279–567(289 aa)
|
Not recorded
|
A1CTJ 2-{2-amino-4-[(morpholin-4-yl)methyl]-1H-1,3-benzimidazol-1-yl}-N-(2,4,6-trichlorophenyl)acetamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;0.1M Bis-Tris pH 5.5, 0.2M MgCl2 and 25% PEG3350
|
Resolution 1.40 Å
R-free 0.208
|
|
9Y8U
Crystal structure of the Kelch domain of human KLHL12 with compound 10j
Deposited 2025-09-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
279–567(289 aa)
|
Not recorded
|
A1CTK 2-(4-{[(3S)-3-(4-cyanopiperidin-1-yl)pyrrolidin-1-yl]methyl}-2-methyl-1H-1,3-benzimidazol-1-yl)-N-(2,4,6-trichlorophenyl)acetamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;0.1M Bis-Tris pH 5.5, 0.2M MgCl2 and 25% PEG3350
|
Resolution 1.01 Å
R-free 0.141
|
|
9Y8V
Crystal structure of the Kelch domain of human KLHL12 with compound 10q
Deposited 2025-09-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
279–567(289 aa)
|
Not recorded
|
A1CTF 2-{4-[(1R,2S)-2-{[(3S)-3-(1,1-dioxo-1lambda~6~-thiomorpholin-4-yl)pyrrolidin-1-yl]methyl}cyclopropyl]-2-methyl-1H-1,3-benzimidazol-1-yl}-N-(2,4,6-trichlorophenyl)acetamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;0.1M Bis-Tris pH 5.5, 0.2M MgCl2 and 25% PEG3350
|
Resolution 1.27 Å
R-free 0.199
|